These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 808781)

  • 41. Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.
    Burk K; Kurth KH; Newling D
    Prog Clin Biol Res; 1989; 303():423-34. PubMed ID: 2780657
    [No Abstract]   [Full Text] [Related]  

  • 42. Local chemotherapy in bladder cancer.
    Gibson GR
    Br J Urol; 1972 Feb; 44(1):121. PubMed ID: 4624722
    [No Abstract]   [Full Text] [Related]  

  • 43. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].
    Jacobi GH; Engelmann U; Frohneberg D; Thüroff JW
    Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunologic and clinical parameters in patients with bladder cancer].
    Sagaster P; Flamn J; Misksche M
    Wien Med Wochenschr; 1977 May; 127(10):315-9. PubMed ID: 327705
    [No Abstract]   [Full Text] [Related]  

  • 47. Laser treatment of bladder cancer.
    Smith JA
    Semin Urol; 1985 Feb; 3(1):2-9. PubMed ID: 3159062
    [No Abstract]   [Full Text] [Related]  

  • 48. Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
    Schulman C; Sylvester R; Robinson M; Smith P; Lachand A; Denis L; Pavone-Macaluso M; De Pauw M; Staquet M
    Recent Results Cancer Res; 1978; 68():338-45. PubMed ID: 111322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
    Iborra Juan I; Monrós Lliso JL; Ricós Torrent JV; Mazcuñan Fuentes F; Casanova Ramón-Borja J; Solsona Narbón E
    Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211
    [No Abstract]   [Full Text] [Related]  

  • 51. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
    Wescott JW
    J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
    Somogyi L; Török A; Bors G; Frang D
    Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN; Kamat MR; Juvekar RL
    Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
    [No Abstract]   [Full Text] [Related]  

  • 55. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 56. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
    Romics I; Dietmar B; Christoph R
    Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [BCG in superficial carcinoma of the bladder. Authors' experience].
    Bordalba Gómez JR; Muñoz Segui J; Aguilo F; Gil Vernet A; Vigues F; Lopez Costea MA; Serrallach N
    Actas Urol Esp; 1992 Jun; 16(6):443-5. PubMed ID: 1509911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Local mitomycin-C therapy of infiltrating bladder cancer].
    Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
    Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
    Stewart AB; Mostafid H
    J Urol; 2005 Apr; 173(4):1433; author reply 1433. PubMed ID: 15758827
    [No Abstract]   [Full Text] [Related]  

  • 60. Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?
    Dobruch J; Herr H
    BJU Int; 2009 Jul; 104(2):170-4. PubMed ID: 19493266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.